Lazard Asset Management
DERM icon

Lazard Asset Management’s Journey Medical DERM Stock Holding History

Lazard Asset Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-44,898
Closed -$211K – 1995
2026
Q1 		$211K Sell
44,898
-17,627
-28% -$137K ﹤0.01% 1616
2025
Q4 		$482K Buy
+62,525
New +$490K ﹤0.01% 1386
2024
Q2 		– Sell
-251
Closed – – 2271
2024
Q1 		$0 Sell
251
-100
-28% -$435 ﹤0.01% 2113
2023
Q4 		$2K Buy
+351
New +$1.56K ﹤0.01% 2161

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Lazard Asset Management's DERM Position: Q2 2026 in Review

Lazard Asset Management sold out of Journey Medical (DERM) in Q2 2026, closing a stake of 44,898 shares — an estimated $211K sold.

Lazard Asset Management first reported a position in DERM in Q4 2023 and held it in 4 quarters. The position peaked at $482K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Lazard Asset Management reported no remaining Journey Medical position as of Q2 2026 after selling out during the quarter.
  • Lazard Asset Management sold 44,898 Journey Medical shares in Q2 2026, an estimated $211K.
  • Lazard Asset Management first reported a position in Journey Medical in Q4 2023 and held it in 4 quarters.
  • Lazard Asset Management's Journey Medical position peaked at $482K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.